文献速递其他结缔组织病

心脏磁共振心肌纤维化、超敏C反应蛋白升高与较高mRSS预测系统性硬化症心血管并发症

Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients.
PubMed 文献 · Semin Arthritis Rheum · 2019-02-11

研究纳入62例系统性硬化症(SSc)患者(29例dcSSc、33例lcSSc),平均随访43.5个月,基线行心脏MRI等评估,分析基线特征与心血管结局的关系。多因素分析显示,超敏C反应蛋白升高与死亡和复发指端缺血性溃疡相关,心肌纤维化(尤其中间段)与心力衰竭相关,较高最大mRSS与冠状动脉疾病相关,附着点纤维化与复发指端缺血性溃疡相关。

要点

  • 基线超敏CRP升高与随访死亡及复发指端缺血性溃疡独立相关。
  • 心肌纤维化尤其中间段受累与随访心力衰竭独立相关。
  • 较高最大mRSS与冠状动脉疾病相关,附着点纤维化与复发指端缺血性溃疡相关。

核心结论

  • 心肌纤维化、超敏C反应蛋白升高和较高最大mRSS是SSc患者心血管结局的独立预测因素。

研究设计与样本

  • 研究纳入62例曾参加心肌纤维化患病率研究(2008-2010)并属于当地SSc队列的患者,29例dcSSc、33例lcSSc,平均随访43.5个月。
  • 基线进行临床评估、心脏MRI、冠状动脉CT血管造影、经胸超声心动图,并每年进行临床与心血管评估,包括Medsger严重度量表条目、心电图、超声心动图、胸部X线或HRCT及肺功能。
  • 采用卡方检验、Fisher检验、Student t检验或Mann-Whitney U检验,并用logistic回归和Cox比例风险比进行多因素分析。

主要发现

  • 基线超敏CRP升高与随访死亡相关(p=0.004,OR 11.9,95%CI 2.1-65.7)。
  • 心肌纤维化尤其中间段受累与随访心力衰竭相关(p=0.01,OR 11.49,95%CI 1.6-83),较高年龄亦与心力衰竭相关(p=0.02,OR 1.11,95%CI 1.01-1.22)。
  • 较高最大mRSS与冠状动脉疾病相关(p=0.02,OR 1.2,95%CI 1.02-1.38),附着点纤维化与复发指端缺血性溃疡相关(p=0.001,OR 12.5,95%CI 2.7-56.6)。

临床怎么用

  • 对SSc患者可结合基线心脏MRI心肌纤维化、超敏CRP和最大mRSS识别心血管并发症高风险人群。
  • 对上述高风险患者应加强心血管结局随访,关注心力衰竭、冠状动脉疾病、指端缺血性溃疡和死亡。
  • 未来研究应聚焦该组患者的早期预防与治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In previous studies we showed that prevalence of myocardial fibrosis as assessed by late enhancement on cardiac MRI in SSc patients is 45% and is associated to diffuse disease (dcSSc) and lower left ventricle ejection fraction; microvascular damage defined as decreased perfusion on cardiac MRI after adenosine infusion, was also very frequent (79%). Our aim was to identify baseline characteristics associated to the development of cardiovascular outcomes (heart failure, coronary artery disease, arrhythmias, vasculopathy, elevated systolic pulmonary artery pressure and death) in SSc patients with previously documented myocardial fibrosis and microvascular damage. PATIENTS AND METHODS: We included 62 SSc patients who participated in the study of prevalence of myocardial fibrosis (2008-2010) and in our local SSc cohort. We performed baseline clinical evaluation, cardiac MRI, coronary CT angiography, transthoracic echocardiogram, and yearly clinical and cardiovascular evaluation that included Medsger's severity scale items, electrocardiogram, echocardiogram, chest X-ray or HRCT and spirometry; we registered presence and severity of internal organ involvement and cardiovascular outcomes. Ordinal variables were analyzed using Chi square test and Fisher test when appropriate, numeric variables were compared using Student's t-test or Mann Whitney U when appropriate, logistic regression and Cox proportional hazard ratio were used to perform multivariable analysis. RESULTS: We obtained follow-up information from 62 patients (29 dcSSc, 33 lcSSc), mean follow-up was 43.5 months. Multivariable analysis showed that elevated basal ultrasensitive CRP was associated to mortality (p = 0.004, OR: 11.9, 95% CI 2.1-65.7) and recurrent digital tip ischemic ulcers (p = 0.001, OR 26.8, 95% CI 3,9-181.3) on follow-up. Myocardial fibrosis, particularly in the middle segments (p = 0.01, OR: 11.49, 95% CI 1.6-83), and older age (p = 0.02, OR: 1.11, 95% CI 1.01-1.22) were associated to heart failure on follow-up. Higher maximum mRSS was associated to coronary artery disease (p = 0.02, OR: 1.2, 95% CI 1.02-1.38), while insertion point fibrosis (p = 0.001, OR: 12.5 95% CI 2.7-56.6) was associated to recurrent digital tip ischemic ulcers. CONCLUSIONS: This study shows that myocardial fibrosis, elevated ultrasensitive CRP, and higher maximum mRSS are independent predictors of cardiovascular outcomes in SSc patients. Future studies should focus on early preventive and therapeutic strategies for this group of patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Reyna TS, Rosales-Uvera SG, Kimura-Hayama E, et al. Myocardial fibrosis detected by magnetic resonance imaging, elevated U-CRP and higher mRSS are predictors of cardiovascular complications in systemic sclerosis (SSc) patients. Semin Arthritis Rheum. 2019. PMID: 30853116. doi:10.1016/j.semarthrit.2019.02.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。